Key Metrics
Avg P/E Ratio
31.2
Profitable Companies
80%
Avg Growth
7.9%
Avg Dividend Yield
0.14%
Historical Return
1 Year
+7.6%
+0.1% Div
3 Years Ø
+13.6%
+0.1% Div
5 Years Ø
+6.2%
+0.1% Div
1 Year
+49.3%
+0.1% Div
3 Years Ø
+5.6%
+0.1% Div
5 Years Ø
+0.2%
+0.1% Div
Risk & Analysis Metrics
Volatility
31.52%
1 Year
26.08%
3 Years
44.54%
5 Years
477.25%
10 Years
Max Drawdown
-32.11%
1 Year
-50.88%
3 Years
-52.49%
5 Years
-59.49%
10 Years
Sharpe Ratio
0.51
1 Year
0.44
3 Years
0.65
5 Years
0.36
10 Years
Volatility
3234.07%
1 Year
1573.18%
3 Years
164.65%
5 Years
1244.24%
10 Years
Max Drawdown
-15.22%
1 Year
-49.00%
3 Years
-62.02%
5 Years
-69.64%
10 Years
Sharpe Ratio
1.96
1 Year
0.63
3 Years
0.70
5 Years
0.52
10 Years
Return Triangle (Heatmap)
| 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2011 | -14.2% | -10.2% | -4.6% | -4.1% | -3.7% | -3.3% | -2.7% | -2.4% | -1.6% | -2.6% | -2.5% | -2.7% | -1.7% | -1.2% | 0.2% |
| 2012 | -6.0% | 0.6% | -0.5% | -0.8% | -1.0% | -0.6% | -0.5% | 0.0% | -1.2% | -1.2% | -1.6% | -0.5% | -0.2% | 1.3% | |
| 2013 | 7.6% | 2.4% | 0.9% | 0.3% | 0.5% | 0.4% | 0.9% | -0.6% | -0.7% | -1.1% | 0.0% | 0.4% | 1.8% | ||
| 2014 | -2.6% | -2.2% | -2.0% | -1.2% | -1.0% | -0.1% | -1.7% | -1.7% | -2.0% | -0.8% | -0.3% | 1.4% | |||
| 2015 | -1.9% | -1.6% | -0.7% | -0.6% | 0.4% | -1.5% | -1.5% | -2.0% | -0.6% | 0.0% | 1.8% | ||||
| 2016 | -1.4% | -0.2% | -0.2% | 0.9% | -1.5% | -1.5% | -2.0% | -0.4% | 0.2% | 2.1% | |||||
| 2017 | 1.1% | 0.5% | 1.7% | -1.5% | -1.5% | -2.1% | -0.3% | 0.4% | 2.5% | ||||||
| 2018 | -0.1% | 2.0% | -2.3% | -2.1% | -2.7% | -0.5% | 0.2% | 2.7% | |||||||
| 2019 | 4.3% | -3.4% | -2.8% | -3.3% | -0.5% | 0.3% | 3.1% | ||||||||
| 2020 | -10.6% | -6.1% | -5.7% | -1.7% | -0.5% | 2.9% | |||||||||
| 2021 | -1.5% | -3.2% | 1.4% | 2.2% | 5.9% | ||||||||||
| 2022 | -4.9% | 2.9% | 3.5% | 7.8% | |||||||||||
| 2023 | 11.4% | 8.0% | 12.4% | ||||||||||||
| 2024 | 4.7% | 12.8% | |||||||||||||
| 2025 | 21.6% |
| 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2011 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 2012 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
| 2013 | - | - | - | - | - | - | - | - | - | - | - | - | - | ||
| 2014 | - | - | - | - | - | - | - | - | - | - | - | - | |||
| 2015 | - | - | - | - | - | - | - | - | - | - | - | ||||
| 2016 | - | - | - | - | - | - | - | - | - | - | |||||
| 2017 | 0.6% | -2.6% | -1.6% | 47.9% | 35.1% | 25.4% | - | - | - | ||||||
| 2018 | -5.8% | -2.7% | 68.2% | 45.4% | 31.0% | - | - | - | |||||||
| 2019 | 0.4% | 124.7% | 68.0% | 42.3% | - | - | - | ||||||||
| 2020 | 403.0% | 117.4% | 59.8% | - | - | - | |||||||||
| 2021 | -6.0% | -9.9% | - | - | - | ||||||||||
| 2022 | -13.6% | - | - | - | |||||||||||
| 2023 | - | - | - | ||||||||||||
| 2024 | 10.8% | 16.8% | |||||||||||||
| 2025 | 23.1% |
Distributions
Last updated: Aug 15, 2026Profit Margin Distribution
P/E Ratio Distribution
Discounted Cash Flow
Weighted Average Undervaluation
N/A
Undervalued
Overvalued
Equal Weight Average Undervaluation
N/A
Undervalued
Overvalued
Portfolio Concentration
81.8%
Top 5 Holdings
88.9%
Top 10 Holdings
99.8%
Top 50 Holdings
100.0%
Top 100 Holdings
Top 5 Companies
Market Cap Size Distribution
Micro: < $300M
Small: $300Mā$2B
Mid: $2Bā$10B
Large: $10Bā$200B
Mega: > $200B
Micro: < $300M
Small: $300Mā$2B
Mid: $2Bā$10B
Large: $10Bā$200B
Mega: > $200B
Latest News
View all news →
9 days ago
• Seeking Alpha
IHF: Healthcare Dashboard For August
The healthcare equipment industry is undervalued based on historical averages, while healthcare providers are near baselines andĀ pharmaceuticals/b...
10 days ago
• The Motley Fool
AbbVie vs. Bristol-Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?
AbbVie demonstrates resilient revenue growth fueled by its next-generation immunology and aesthetics portfolio. Bristol-Myers Squibb maintains high...
10 days ago
• GlobeNewsWire
Kaplan Fox Notifies Alignment Healthcare, Inc. (NASDAQ: ALHC) Investors of an Investigation into Potential Securities Law Violations
NEW YORK, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthca...
Average metrics of all companies in sector Last updated: Aug 23, 2026
Compare to Market
| Market Cap The average market value of companies in this sector. | $10.6B | |
| Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. | 0.14 % | |
| Beta Indicates the relationship between the price performance of a share and the market. | 0.61 | |
| P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. | 31.22 | |
| Negative P/E Ratio A negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything. | -24.23 | |
| Profitable Companies | 80% | |
| PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. | -28.47 | |
| Price to Sales Ratio Market cap divided by the revenue in the most recent year. | 6.8 | |
| Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company. | 5.8 |
Compare to Market
| Enterprise Value to EBIT Enterprise Value divided by EBIT. | 29.19 | |
| Enterprise Value to Revenue Enterprise value divided by revenue. | 7.11 | |
| Total Debt to Enterprise Value Total debt divided by enterprise value. | 0.09 | |
| Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. | 0.5 | |
| Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. | 11.63% | |
| Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. | +7.9% | |
| Return on Equity Equity divided by market cap. | 6.17% | |
| Return on Assets Indicates a company's profitability in relation to its total assets. | 2.58% | |
| Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. | 6.39% |
Stock Screener
Select filters to narrow down the 145 companies below
145 companies
Market Cap
$175.45B
Dividends
0.0%
P/E Ratio
20.3
Revenue
$5.44B
+7.5%
Net Income
$907M
+13.8%
Profit Margin
+16.7%
Employees
45K
View Stock
Market Cap
$175.45B
Dividends
0.0%
P/E Ratio
20.3
Revenue
$5.44B
+7.5%
Net Income
$907M
+13.8%
Profit Margin
+16.7%
Employees
45K
View Stock
Market Cap
$39.84B
Dividends
1.1%
P/E Ratio
61.0
Revenue
$5.77B
+38.2%
Net Income
$109M
-63.5%
Profit Margin
+1.9%
Employees
22.05K
View Stock
Market Cap
$28.97B
Dividends
0.0%
P/E Ratio
39.8
Revenue
$7.69B
+11.6%
Net Income
$60M
-82.0%
Profit Margin
+0.8%
Employees
43K
View Stock
Market Cap
$6.51B
Dividends
0.0%
P/E Ratio
-43.7
Revenue
$0.00
Net Income
-$41.2M
+67.7%
Profit Margin
Employees
28
View Stock
Market Cap
$6.51B
Dividends
0.0%
P/E Ratio
-43.7
Revenue
$0.00
Net Income
-$41.2M
+67.7%
Profit Margin
Employees
28
View Stock
Market Cap
$5.96B
Dividends
0.0%
P/E Ratio
-13.1
Revenue
$0.00
Net Income
-$159M
+271.9%
Profit Margin
Employees
74
View Stock
Market Cap
$5.96B
Dividends
0.0%
P/E Ratio
-13.1
Revenue
$0.00
Net Income
-$159M
+271.9%
Profit Margin
Employees
74
View Stock
Market Cap
$5.74B
Dividends
0.0%
P/E Ratio
-18.6
Revenue
$837M
+15.6%
Net Income
-$183M
-12.4%
Profit Margin
-21.9%
Market Cap
$4.59B
Dividends
0.0%
P/E Ratio
-1.1
Revenue
$148k
Net Income
-$52.5M
Profit Margin
-35448.0%
Employees
145
View Stock
Market Cap
$4.37B
Dividends
0.0%
P/E Ratio
137.7
Revenue
$109M
+64.4%
Net Income
$8.05M
-3374.0%
Profit Margin
+7.4%
Employees
620
View Stock
Market Cap
$4.3B
Dividends
0.0%
P/E Ratio
-48.0
Revenue
$0.00
Net Income
-$23.5M
Profit Margin
Employees
21
View Stock
Market Cap
$3.16B
Dividends
0.0%
P/E Ratio
-27.6
Revenue
$0.00
Net Income
-$37.1M
+91.1%
Profit Margin
Employees
43
View Stock
Market Cap
$2.54B
Dividends
0.0%
P/E Ratio
-33.0
Revenue
$29M
+24.1%
Net Income
-$12.9M
-6.7%
Profit Margin
-44.5%
Employees
225
View Stock
Market Cap
$2.54B
Dividends
0.0%
P/E Ratio
-33.0
Revenue
$29M
+24.1%
Net Income
-$12.9M
-6.7%
Profit Margin
-44.5%
Employees
225
View Stock
Market Cap
$2.4B
Dividends
0.0%
P/E Ratio
36.1
Revenue
$352M
+2.2%
Net Income
$21.9M
+142.2%
Profit Margin
+6.2%
Employees
3.4K
View Stock
Market Cap
$2.37B
Dividends
0.0%
P/E Ratio
-64.6
Revenue
$29.4M
Net Income
-$13.2M
Profit Margin
-44.9%
Employees
222
View Stock
Market Cap
$2.3B
Dividends
0.0%
P/E Ratio
-37.5
Revenue
$0.00
Net Income
-$24.2M
Profit Margin
Employees
72
View Stock
Market Cap
$2.22B
Dividends
0.0%
P/E Ratio
-9.8
Revenue
$0.00
Net Income
-$111M
Profit Margin
Employees
145
View Stock
Market Cap
$2.04B
Dividends
0.0%
P/E Ratio
-3.4
Revenue
$1M
Net Income
-$111M
+113.6%
Profit Margin
-11145.6%
Employees
130
View Stock